日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

New brain cancer therapy may launch in China

By Liu Zhihua | chinadaily.com.cn | Updated: 2019-05-21 15:09
Share
Share - WeChat
Several medicines to treat the disease have already started phase-two clinical trials in China. [Photo/VCG]

Thanks to joint efforts by Chinese pharmaceutical companies and medical professionals, Chinese patients suffering from glioblastoma multiforme, the most aggressive cancer that begins within the brain, are likely to have more options for treatment, a key medical expert said.

Li Wenbin, deputy chief of the glioblastoma multiforme branch of the China Anti-Aancer Association, said Optune, a cancer therapy that uses electric fields tuned to specific frequencies to disrupt cell division, inhibiting tumor growth and causing affected cancer cells to die, will probably be approved for commercialization in the Chinese mainland within the year, marking a milestone of progress for the disease care.

Statistically, about five to eight people out of 100,000 will get glioma every year, with about half of them diagnosed with glioblastoma multiforme, which has a five-year survival rate of less than 5 percent, Li said, adding that the median survival time for patients is only about 14.6 months.

The combined use of Optune and classic treatments including operation, radiotherapy and chemical therapy can extend patients' median survival time to about 20 months, according to Li, who is also the director of the neuro-oncology department of Beijing Tiantan Hospital, a comprehensive hospital renowned for expertise in neurology and neurosurgery.

Besides, several medicines to treat the disease have already started phase-two clinical trials in China, including two first-in-class trials led by Li which have delivered promising results.

Both of the medicines are developed by Chinese pharmaceutical companies, Li said.

Li made the remarks at a media interview during a forum held recently in Beijing on new technologies for treating glioblastoma multiforme.

Zai Lab, a Shanghai-based innovative biopharmaceutical company, licensed the technology from the NASDAQ-listed oncology company Novocure in September 2018 for the Chinese mainland, Hong Kong, Macao and Taiwan markets, and has launched it in Hong Kong. Novocure has been marketed as Optune in the United States, Europe and Japan.

While Optune is not yet approved for commercialization in China, the technology was included and recommended as a treatment for glioblastoma multiforme in China's Glioma Treatment Guideline published in 2016. In December 2018, the national treatment guideline was expanded to include both newly diagnosed and recurrent glioblastoma multiforme patients.

Zai Lab told China Daily that it is preparing documents to file a market launch application for Optune as an innovative medical device to China's National Medical Products Administration, and hopes to launch it on the Chinese mainland within the year if the NMPA accepts its request for a clinical trial waiver.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 99pao成人国产永久免费视频 | 一本色道久久88综合亚洲精品高清 | 丰满岳妇乱一区二区三区 | 精品欧美日韩 | 黄色小视频在线观看 | 国产精品三级在线 | 欧美另类色图 | 亚洲综合无码一区二区 | 我想看免费毛片 | 一级特黄aa大片欧美 | 欧美videosex性极品hd | 日韩不卡在线 | 国产成人免费永久播放视频平台 | 精品国产欧美 | a级片在线免费播放 | 亚洲免费观看视频 | 天天做天天爱天天影视综合 | 国产精品久久久久无码人妻 | 日韩欧美一区二区不卡 | 国产精品果冻麻豆精东天美 | 99riav在线| 天天干天操 | 91最新在线视频 | 亚洲成人精品 | 成人午夜亚洲影视在线观看 | 九九热久久免费视频 | 韩国美女激情视频一区二区 | 五月婷在线| 国产噜噜噜精品免费 | 亚洲天堂2013 | 一区影院 | 午夜性刺激在线观看视频 | 成人久久精品一区二区三区 | 中国美女一级黄色片 | 97av视频| 中文字幕一区二区三区四区 | 亚洲国产aⅴ成人精品无吗 国内成人自拍视频 | 欧美伊人 | 色人人| 国产日韩精品一区二区 | 性欧美xxxx极品摘花 |